Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
TORIGEN PHARMACEUTICALS, INC. See All Filings	D	2022-05-24 17:17:01 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers N/A CIK Number 0001764961 Filed Document 0001764961-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-05-24 17:17:01 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CONNECTICUT Revenue or Assets Decline to Disclose Type of Security Equity
TORIGEN PHARMACEUTICALS, INC. See All Filings	D	2021-12-06 16:06:16 UTC
Amount To Be Raised $1,500,000 Associated Brokers / Dealers N/A CIK Number 0001764961 Filed Document 0001764961-21-000002 Exclusions or Exemptions 506b Accepted Date 2021-12-06 16:06:16 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CONNECTICUT Revenue or Assets Decline to Disclose Type of Security Debt
TORIGEN PHARMACEUTICALS, INC. See All Filings	D/A	2021-03-04 18:59:15 UTC
Amount To Be Raised $3,500,000 Associated Brokers / Dealers N/A CIK Number 0001764961 Filed Document 0001764961-21-000001 Exclusions or Exemptions 506b Accepted Date 2021-03-04 18:59:15 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business CONNECTICUT Revenue or Assets Decline to Disclose Type of Security Debt
TORIGEN PHARMACEUTICALS, INC. See All Filings	D	2020-06-16 13:10:47 UTC
Amount To Be Raised $1,500,000 Associated Brokers / Dealers N/A CIK Number 0001764961 Filed Document 0001764961-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-06-16 13:10:47 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CONNECTICUT Revenue or Assets Decline to Disclose Type of Security Debt
TORIGEN PHARMACEUTICALS, INC. See All Filings	D	2019-01-16 16:20:48 UTC
Amount To Be Raised $2,000,000 Associated Brokers / Dealers N/A CIK Number 0001764961 Filed Document 0001764961-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-01-16 16:20:48 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CONNECTICUT Revenue or Assets Decline to Disclose Type of Security Equity